Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

LONDON MARKET OPEN: Stocks stay green as UK CPI stirs cut speculation

14th Aug 2024 08:36

(Alliance News) - Stock prices in London started the day in the green, even after local economic data showed an acceleration in UK consumer price inflation for the first time since December. Read More

LONDON MARKET MIDDAY: Stocks turn red as sentiment sours before US PPI

13th Aug 2024 11:52

(Alliance News) - Stock prices in London were in the red at midday, as investor sentiment turned ahead of the next inflationary print from the US this afternoon. Read More

AstraZeneca and Daiichi Sankyo get new approval in China for Enhertu

13th Aug 2024 11:38

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Tuesday said their joint product Enhertu has received a third approval in China. Read More

UK dividends calendar - next 7 days

1st Aug 2024 14:32

IN BRIEF: AstraZeneca prices EUR1.4 billion in bonds at 3.1% and 3.3%

30th Jul 2024 15:59

AstraZeneca PLC - Cambridge, England-based biopharmaceutical maker - Prices two tranches of eurobonds, raising a total of EUR1.40 billion for "general corporate purposes". Issues EUR650 million in fixed-rate notes with a coupon of 3.121% maturing in August 2030, and EUR750 million in fixed-rate notes with a coupon of 3.278% maturing in August 2033. The offering, by subsidiary AstraZeneca Finance LLC, is run by BNP Paribas, Goldman Sachs International, Morgan Stanley and Societe Genarale as joint book-running managers. Read More

Astra's breast cancer drug not recommended for NHS use due to price

29th Jul 2024 15:37

(Alliance News) - A life-extending drug for incurable breast cancer will not be made available on the health service in England after its manufacturers and the NHS spending watchdog failed to reach an agreement on price. Read More

LONDON BROKER RATINGS: Citigroup lifts BAE; Morgan Stanley cuts Drax

29th Jul 2024 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

AstraZeneca reports positive findings from ongoing leukaemia trial

29th Jul 2024 08:37

(Alliance News) - AstraZeneca PLC on Monday said a study showed a leukaemia treatment significantly improved progression-free survival in patients with chronic lymphocytic leukaemia. Read More

EXECUTIVE CHANGES: Morgan Advanced Materials picks senior director

26th Jul 2024 15:27

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Astra pushes to get Imfinzi approved for lung cancer in US

26th Jul 2024 13:27

AstraZeneca PLC - Cambridge, England-based pharmaceutical firm - Says it is "committed to working closely" with the US Food & Drug Administration to bring an Imfinzi-based treatment to patients with resectable non-small cell lung cancer, following a review of a phase III trial by the Oncologic Drugs Advisory Committee, an advisory body for the FDA. Astra says the Aegean trial of Imfinzi, whose generic name is durvalumab, showed a "statistically significant and clinically meaningful 32% reduction in the risk of recurrence, progression events or death versus chemotherapy alone". Read More

LONDON BROKER RATINGS: Greencore and Hammerson cut to 'hold'

26th Jul 2024 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET MIDDAY: Drab earnings unnerve equities before US data

25th Jul 2024 12:10

(Alliance News) - European equities tumbled on Thursday, with tepid earnings causing a sea of red across major benchmarks, compounding already fragile sentiment after a sell-off in New York. Read More

Good not "good enough" for Astra as stock down despite outlook bump

25th Jul 2024 11:38

(Alliance News) - AstraZeneca PLC shares came under pressure, despite stronger earnings and a guidance hike on Thursday. Read More

TOP NEWS: AstraZeneca shares fall despite improved full-year outlook

25th Jul 2024 09:37

(Alliance News) - AstraZeneca PLC on Thursday raised its annual guidance as it hailed "strong growth in the first half of the year". Read More

LONDON MARKET OPEN: Earnings woe sends European stocks lower

25th Jul 2024 08:54

(Alliance News) - Stock prices in London opened lower on Thursday, with earnings from the UK and beyond largely falling short, after sentiment was already hurt by a tech sell-off in New York. Read More

LONDON BRIEFING: Astra ups outlook; Unilever and Lloyds back view

25th Jul 2024 07:49

(Alliance News) - London's FTSE 100 is called to open lower on Thursday, with a sell-off of US technology shares filtering through to trade in Europe and in Asia. Read More

UK earnings, trading statements calendar - next 7 days

19th Jul 2024 15:32

UK earnings, trading statements calendar - next 7 days

18th Jul 2024 16:07

AstraZeneca lofty revenue aim looks "readily deliverable" — Shore

12th Jul 2024 14:25

(Alliance News) - AstraZeneca PLC's recently announced aim of delivering USD80 billion in yearly revenue by the start of the next decade looks achievable, Shore Capital Markets said Friday, believing the drugmaker has an enviable pipeline. Read More

LONDON BROKER RATINGS: Barclays raises Kerry, cuts Hunting, Wood Group

10th Jul 2024 10:08

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

FTSE 100 Latest

Value8,275.66

Change0.00